With a revenue increase of 39.49% in the second quarter 2026, year on year to cumulative value of $3,374 million, Neurocrine Biosciences Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,686,950, this is below the company average.
Within the Healthcare sector Employees of 49 other companies have achieved higher revenue per employee. While Neurocrine Biosciences Inc 's total ranking has deteriorated compared to the previous quarter from 233 to 556. Neurocrine Biosciences Inc has 2,000 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBIX Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	39.49 %	42.25 %	28.33 %	27.78 %	16.49 %
Sales per Employee (TTM) $	1,686,950	1,551,200	1,430,250	1,341,350	1,254,950
NBIX's Total Ranking	# 556	# 233	# 109	# 59	# 191
Seq. Revenue Change	17.74 %	1.12 %	1.33 %	15.62 %	20.07 %

NBIX Company Profile >> Back to NBIX Efficiency Comparisons >> Compare NBIX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 9
Healthcare Sector	# 50
Overall Market	# 556

Revenue per Employee Statistics
High	Average	Low
$ 1,551,200	$ 659,211	$ 12,068
(Mar 31 2026)		(Dec 31 2013)

Financial Statements
Neurocrine Biosciences Inc 's Revenue MRQ	$ 959 Millions	Visit NBIX's Income Statement
Neurocrine Biosciences Inc 's Revenues TTM	$ 3,374 Millions	Visit NBIX's aggregate revenue growth
What are NBIX's Sales?		Visit NBIX's Sales by Segment

Other Ratios
Neurocrine Biosciences Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NBIX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NBIX's Competitors
Revenue per Employee for NBIX's Suppliers
Revenue per Employee for NBIX's Customers

You may also want to know
NBIX's Sales Growth Rates	NBIX's Pe Price to earnings ratio	NBIX's Receivables Turnover Ratio	NBIX's Stock Quote
NBIX's Net Income Growth Rates	NBIX's Ps Price to Sales ratio	NBIX's Sales per Employee	NBIX's Asset Turnover Ratio
NBIX's Net Margin	NBIX's Pb Price to Book ratio	NBIX's Financial Strength Ratios	NBIX's Dividend Payout Ratio

Date modified: 2026-08-31T07:05:19+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Amgen Inc	2,930,384.62	$ 38,095.000 Million	13,000
Innoviva Inc	2,645,471.70	$ 420.630 Million	159
Aurinia Pharmaceuticals Inc	2,433,648.44	$ 311.507 Million	128
Eton Pharmaceuticals Inc	2,392,704.55	$ 105.279 Million	44
Cormedix Inc	2,366,196.28	$ 451.943 Million	191
Sarepta Therapeutics Inc	2,364,483.83	$ 1,974.344 Million	835
United Therapeutics Corporation	2,253,214.29	$ 3,154.500 Million	1,400
Biocryst Pharmaceuticals Inc	2,162,328.74	$ 940.613 Million	435
Elite Pharmaceuticals Inc	2,155,839.86	$ 140.130 Million	65
Protagonist Therapeutics inc	2,136,303.03	$ 281.992 Million	132
Exelixis Inc	2,123,731.47	$ 2,435.920 Million	1,147
Zevra Therapeutics Inc	2,112,377.05	$ 128.855 Million	61
Liquidia Corporation	2,087,532.41	$ 450.907 Million	216
Tg Therapeutics Inc	2,003,849.62	$ 799.536 Million	399
Prestige Consumer Healthcare Inc	1,938,521.05	$ 1,104.957 Million	570
Privia Health Group Inc	1,923,384.18	$ 2,358.069 Million	1,226
Alnylam Pharmaceuticals Inc	1,921,672.80	$ 4,804.182 Million	2,500
Gilead Sciences Inc	1,791,588.24	$ 30,457.000 Million	17,000
Collegium Pharmaceutical Inc	1,777,172.58	$ 751.744 Million	423
Fennec Pharmaceuticals Inc	1,692,028.57	$ 59.221 Million	35
Neurocrine Biosciences Inc	1,686,950.00	$ 3,373.900 Million	2,000
Mirum Pharmaceuticals Inc	1,661,470.43	$ 618.067 Million	372
Tarsus Pharmaceuticals Inc	1,638,732.43	$ 606.331 Million	370
Agenus Inc	1,638,185.19	$ 132.693 Million	81
Xenetic Biosciences Inc	1,630,388.50	$ 3.261 Million	2
Ideaya Biosciences Inc	1,614,668.97	$ 234.127 Million	145
Eli Lilly And Company	1,593,316.00	$ 79,665.800 Million	50,000
Jazz Pharmaceuticals Plc	1,592,122.15	$ 4,601.233 Million	2,890
Rigel Pharmaceuticals Inc	1,590,718.39	$ 276.785 Million	174
Progyny Inc	1,531,890.19	$ 1,311.298 Million	856

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.